The majority of respondents to a recent UK government consultation agree with the European Commission's proposal to allow the pharmaceutical industry to provide patients with non-promotional information on prescription medicines1. However, a third of those who responded disagree with the plan, mainly on the grounds that any information disseminated by pharmaceutical companies is by its nature promotional
...
Please login to read the full article.
